Zaleplon
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0054-0084 -
Package NDC
0054-0084-25 -
Application number
ANDA077237 -
SPL ID
d97e7e61-defc-47f5-aeca-11cecae47e79 -
SPL set ID
cadd9d75-2139-4fab-94ce-2992e6a55780 -
UNII
S62U433RMH -
RxCUI
313761 -
RxCUI
313762
What the source publishes
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Active ingredients
- Zaleplon
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Zaleplon",
"splId": "d97e7e61-defc-47f5-aeca-11cecae47e79",
"labels": [
{
"setId": "cadd9d75-2139-4fab-94ce-2992e6a55780",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cadd9d75-2139-4fab-94ce-2992e6a55780",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cadd9d75-2139-4fab-94ce-2992e6a55780"
}
],
"routes": [
"ORAL"
],
"labeler": "Hikma Pharmaceuticals USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (0054-0084-25)",
"package_ndc": "0054-0084-25",
"identifierStatus": "well-formed",
"marketing_start_date": "20080606"
}
],
"productId": "0054-0084_d97e7e61-defc-47f5-aeca-11cecae47e79",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "0054-0084",
"deaSchedule": "CIV",
"genericName": "Zaleplon",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ZALEPLON",
"strength": "5 mg/1"
}
],
"applicationNumber": "ANDA077237",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20080606",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000183360",
"N0000000196",
"N0000175728"
],
"upc": [
"0300540085254",
"0300540084257"
],
"unii": [
"S62U433RMH"
],
"rxcui": [
"313761",
"313762"
],
"spl_set_id": [
"cadd9d75-2139-4fab-94ce-2992e6a55780"
],
"pharm_class_pe": [
"Central Nervous System Depression [PE]"
],
"pharm_class_epc": [
"gamma-Aminobutyric Acid A Receptor Agonist [EPC]"
],
"pharm_class_moa": [
"GABA A Agonists [MoA]"
],
"manufacturer_name": [
"Hikma Pharmaceuticals USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0054-0084_d97e7e61-defc-47f5-aeca-11cecae47e79"